Sight Sciences (SGHT) EBIAT (2020 - 2025)
Sight Sciences has reported EBIAT over the past 6 years, most recently at -$4.1 million for Q4 2025.
- Quarterly results put EBIAT at -$4.1 million for Q4 2025, up 65.39% from a year ago — trailing twelve months through Dec 2025 was -$38.4 million (up 25.43% YoY), and the annual figure for FY2025 was -$38.4 million, up 25.45%.
- EBIAT for Q4 2025 was -$4.1 million at Sight Sciences, up from -$8.2 million in the prior quarter.
- Over the last five years, EBIAT for SGHT hit a ceiling of -$4.1 million in Q4 2025 and a floor of -$23.8 million in Q2 2022.
- Median EBIAT over the past 5 years was -$14.5 million (2023), compared with a mean of -$14.7 million.
- Biggest five-year swings in EBIAT: crashed 112.04% in 2021 and later surged 65.39% in 2025.
- Sight Sciences' EBIAT stood at -$15.9 million in 2021, then dropped by 6.09% to -$16.9 million in 2022, then skyrocketed by 36.77% to -$10.7 million in 2023, then dropped by 10.8% to -$11.8 million in 2024, then surged by 65.39% to -$4.1 million in 2025.
- The last three reported values for EBIAT were -$4.1 million (Q4 2025), -$8.2 million (Q3 2025), and -$11.9 million (Q2 2025) per Business Quant data.